Optimizing the first-line fertility treatment

被引:4
|
作者
Irani, Mohamad [1 ]
Chow, Stephen [1 ]
Keating, Derek [1 ]
Elder, Simone [2 ]
Rosenwaks, Zev [1 ]
Palermo, Gianpiero [1 ]
机构
[1] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med, New York, NY USA
关键词
Clomiphene citrate; endometrial thickness; follicle; intrauterine insemination; total motile spermatozoa; INTRAUTERINE INSEMINATION; SPERM MORPHOLOGY; ENDOMETRIAL THICKNESS; PREDICTIVE-VALUE; PREGNANCY; INFERTILITY; MANAGEMENT; PROGNOSIS; NUMBER; IUI;
D O I
10.1080/09513590.2018.1441825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to identify sperm score thresholds to achieve satisfactory intrauterine insemination (IUI) success rates according to the response to stimulation with clomiphene citrate (CC). To minimize the confounding effect of female age, we included only CC/IUI cycles of women 35years old. A total of 1,194CC/IUI cycles were included. Semen volume, concentration, and motility influenced the clinical pregnancy rate (CPR). Normal morphology (4%) was associated with a comparable CPR with 3%, 2%, and 1% normal forms (15.6%, 16.1%, 18.1%, and 13.1%, respectively). A combination of the total number of motile spermatozoa in the ejaculate before semen preparation (TM) at a threshold 20x10(6) was associated with a CPR of 17.8% compared to 4.6% for a threshold <20x10(6) (p<.001). Interestingly, the TM threshold to achieve satisfactory outcomes was lower (10x10(6)) in patients who had an optimal response to CC (2 dominant follicles with an endometrial thickness7mm) compared to 40x10(6) for those who had a suboptimal response (one dominant follicle with an endometrial thickness <7mm). In conclusion, the response to superovulation with CC determines each patient's TM threshold required for satisfactory outcomes. Couples whose TM is below the threshold may benefit from a superovulation with gonadotropins or in vitro fertilization.
引用
收藏
页码:742 / 746
页数:5
相关论文
共 50 条
  • [42] Combination therapy as first-line treatment for hypertension
    Irene Gavras
    Talma Rosenthal
    Current Hypertension Reports, 2004, 6 : 267 - 272
  • [43] First-line treatment of pelvic organ prolapse
    Umachanger, Kantharooban J.
    Marcussen, M.
    Bogild, H.
    Kjaergaard, N.
    Glavind, K.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2018, 29 : S60 - S60
  • [44] Monotherapy or Polytherapy for First-Line Treatment of SE?
    Alvarez, Vincent
    Rossetti, Andrea O.
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2016, 33 (01) : 14 - 17
  • [45] First-line treatment of advanced colorectal cancer
    Hewish, Madeleine
    Cunningham, David
    LANCET, 2011, 377 (9783): : 2060 - 2062
  • [46] Combination therapy as first-line treatment for hypertension
    Gavras, I
    Rosenthal, T
    CURRENT HYPERTENSION REPORTS, 2004, 6 (04) : 267 - 271
  • [47] Irinotecan in the first-line treatment of colorectal cancer
    Saltz, LB
    ONCOLOGY-NEW YORK, 1998, 12 (08): : 54 - 58
  • [48] Combination Therapy as First-Line Treatment for Hypertension
    Michael H. Crawford
    American Journal of Cardiovascular Drugs, 2009, 9 (1) : 1 - 6
  • [49] First-Line Treatment of Metastatic Pancreatic Cancer
    Tokh, Mohammed
    Bathini, Venu
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2012, 13 (02): : 159 - 162
  • [50] First-line treatment of metastatic breast cancer
    Trudeau, ME
    ANTI-CANCER DRUGS, 1996, 7 : 9 - 12